VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $82,000 | +164.5% | 3,540 | +86.8% | 0.01% | +66.7% |
| Q1 2018 | $31,000 | -60.3% | 1,895 | -36.2% | 0.00% | -70.0% |
| Q4 2017 | $78,000 | -53.6% | 2,972 | -68.3% | 0.01% | -28.6% |
| Q3 2017 | $168,000 | +630.4% | 9,363 | +836.3% | 0.01% | +366.7% |
| Q2 2017 | $23,000 | +2200.0% | 1,000 | +900.0% | 0.00% | – |
| Q1 2017 | $1,000 | -93.8% | 100 | -91.2% | 0.00% | -100.0% |
| Q4 2016 | $16,000 | -96.9% | 1,134 | -94.7% | 0.00% | -96.2% |
| Q3 2016 | $520,000 | +303.1% | 21,198 | +231.0% | 0.05% | +333.3% |
| Q2 2016 | $129,000 | -18.4% | 6,405 | +6.7% | 0.01% | -50.0% |
| Q1 2016 | $158,000 | -50.0% | 6,003 | +93.0% | 0.02% | -52.9% |
| Q4 2015 | $316,000 | -61.4% | 3,110 | -9.6% | 0.05% | -36.2% |
| Q3 2015 | $819,000 | +116.7% | 3,441 | +102.4% | 0.08% | +135.3% |
| Q2 2015 | $378,000 | -82.8% | 1,700 | -80.7% | 0.03% | -87.5% |
| Q1 2015 | $2,199,000 | +2370.8% | 8,789 | +1301.8% | 0.27% | +2922.2% |
| Q4 2014 | $89,000 | -61.1% | 627 | -59.8% | 0.01% | -65.4% |
| Q3 2014 | $229,000 | +114.0% | 1,560 | +84.0% | 0.03% | +85.7% |
| Q2 2014 | $107,000 | -94.9% | 848 | -94.7% | 0.01% | -94.8% |
| Q1 2014 | $2,117,000 | +105750.0% | 16,055 | +114578.6% | 0.27% | – |
| Q4 2013 | $2,000 | -93.5% | 14 | -95.2% | 0.00% | -100.0% |
| Q3 2013 | $31,000 | -94.9% | 294 | -95.6% | 0.00% | -94.0% |
| Q2 2013 | $610,000 | – | 6,724 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |